Untested, Unapproved Compounded Hormone Prescriptions Reach 26 to 33 Million a Year Despite the risks, the number approaches that for FDA-approved hormone therapies CLEVELAND, Ohio (December 18, 2015)—The number of prescriptions for mostly unregulated compounded hormone therapy for women at ...

After Menopause, Vulvovaginal Troubles Are Common and Linked with Other Pelvic Problems Nevertheless, over 30% of women haven’t seen a gynecologist, and over 80% didn’t get the standard treatment CLEVELAND, Ohio (December 9, 2015)—After menopause, more than half of women ...

Contributed by Mache Seibel, MD- Red Hot Mamas Medical Expert At this year’s Annual Meeting of the North American Menopause Society, there was a lot of discussion about the safety of vaginal estrogen. It turns out that of the 64 million ...

Important news…the FDA will be holding a public workshop on Labeling “Lower” Dose Estrogen-Alone Products for Symptoms of Vulvar and Vaginal Atrophy (VVA) on November 10, 2015  that you may be interested in. This workshop will be held on the White ...

New Study Demonstrates Combined Impact of Smoking and Early Menopause On Mortality  Current smokers who experienced early menopause expected to die 2.6 years earlier CLEVELAND, Ohio (August 4, 2015) — Women may now have yet another reason to quit smoking ...

The North American Menopause Society (NAMS) announces the June 2, 2015, online publication of its statement, “The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65,” and the accompanying editorial, “NAMS Supports Judicious Use ...

The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65 The 2012 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) states that hormone therapy (HT) is the most effective treatment for ...